@alexblakes.bsky.social
46 followers 110 following 16 posts
Posts Media Videos Starter Packs
Reposted
nickywhiffin.bsky.social
I absolutely love this figure in a second paper led by Adam Jackson, @alexblakes.bsky.social, and Sid Banka (www.medrxiv.org/content/10.1...) of RNU gene diagnoses in @genomicsengland.bsky.social 100k genomes project.

(1) showing just how many new diagnoses are found across these genes ❤️

2/3
Two pie charts. On the left, a small segment of a grey pie chart labelled 'Unsolved NDD (N=7,968, 100%)' is shaded dark. A zoom out from this small segment shows individuals with new "RNU-opathies" in 100KGP (N=118, 1.48%). This has five segments, in order of size: (1) RNU4-2 dominant (N=59, 0.74%), (2) RNU2-2 recessive (N=38, 0.48%), (3) RNU2-2 dominant (N=11, 0.14%), (3) RNU4-2 recessive (N=5, 0.06%), (4) RNU5B-1 dominant (N=5, 0.06%).
alexblakes.bsky.social
The biology here is fascinating too. Really nice to see the clustering of compound het / homozygous variants in the Sm site in your cohort for example.
alexblakes.bsky.social
Congratulations to you and the whole team on this really beautiful work. This is a really important discovery for patients and families affected by rare conditions.
christeldepienne.bsky.social
We analyzed 200 potentially functional spliceosomal snRNA genes in 26,911 individuals with rare disorders.
This revealed de novo (dominant) or biallelic (recessive) RNU2-2 variants in 126 individuals from 108 families.
Reposted
ewanbirney.bsky.social
This is ... just brilliant. Another ncRNA gene involved in rare developmental diseases, and these are a meaningful number of new cases - also interesting the dominance/linear/recessive differences
nickywhiffin.bsky.social
While I was taking a holiday last week, 2 super exciting preprints dropped, adding to another posted 6 days prior.

These papers describe a remarkable role for *recessive* variants in *RNU2-2* causing developmental and epileptic encephalopathy

🧵 by the amazing @christeldepienne.bsky.social 👇

1/3
christeldepienne.bsky.social
After our study on RNU4-2 and RNU5B-1 published in May (Nava et al, Nature Genetics 2025), I am excited to share our new preprint reporting dominant and recessive variants in RNU2-2 as a frequent cause of developmental and epileptic encephalopathy (DEE).

📄 www.medrxiv.org/content/10.1...
Reposted
nickywhiffin.bsky.social
(2) but even cooler is the flip of frequency between dominant and recessive forms in RNU4-2 and RNU2-2, driven by different signatures of mutation and selection - variants across RNU2-2 tend to be more common, driving a higher comp het frequency.

We have a lot to learn from these genes yet!!! 🧬🤓
Reposted
nickywhiffin.bsky.social
While I was taking a holiday last week, 2 super exciting preprints dropped, adding to another posted 6 days prior.

These papers describe a remarkable role for *recessive* variants in *RNU2-2* causing developmental and epileptic encephalopathy

🧵 by the amazing @christeldepienne.bsky.social 👇

1/3
Reposted
ruebenadawes.bsky.social
Love when you can build a paper out of a personal bugbear! tl;dr the precomputed SpliceAI scores are great, but proceed with caution!
Reposted
lcpilling.bsky.social
Very exciting to have access to "Our Future Health" data and begin understanding what is available and how to access it

Many thanks to the volunteers so far. Still a long way to go - consider signing up if you haven't already!

This is a greater primer on the aims www.nature.com/articles/s41...
Our Future Health: a unique global resource for discovery and translational research - Nature Medicine
Our Future Health has recruited more than 1 million participants in the UK, with biobanked bloods, making it the largest consented cohort of its type in the world.
www.nature.com
Reposted
yuyangchen.bsky.social
1st Bluesky post with recent updates:
1/3 It was incredible to attend and speak at the ReNU Hope Conference in Long Island, NY. This was the first time I met the families and the ReNU warriors, sharing many touching stories. I hope to continue advocacy in China where few are currently diagnosed.
Reposted
gregfindlay.bsky.social
Our latest research is out today on ‪@medrxivpreprint.bsky.social:

www.medrxiv.org/content/10.1...

Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk.

Led by the amazing Phoebe Dace. This one’s packed full of data, so check out the paper. Quick highlights… 🧵 1/n
Saturation genome editing of BRCA1 across cell types accurately resolves cancer risk
Germline pathogenic BRCA1 variants predispose women to breast and ovarian cancer. Despite accumulation of functional evidence for variants in BRCA1 , over half of reported single-nucleotide variants (...
www.medrxiv.org
Reposted
nickywhiffin.bsky.social
Isn't genetics cool???

Within only 145 nucleotides(!) of a non-coding RNA (RNU4-2) - different variants in distinct regions / structures cause three distinct disorders!!! (all discovered within the last 18 months)

🤯🤓🧬❤️
Schematic of the U4 and U6 snRNAs with coloured annotations to note nucleotides linked to different disorders:
- Teal in the T-loop and Stem III for ReNU syndrome (Chen et al. Nature 2024 and Greene et al. Nature Medicine 2024)
- Red for variants causing a recessive NDD in Stem II, the k-turn and Sm protein binding sites (De Jonghe et al. medRxiv 2025 and Rius & Blakes medRxiv 2025)
- Yellow for the central loop and Retinitis pigmentosa (Quinodoz et al. medRxiv 2025)
Reposted
jeffbarrett.eu
Look at the insane speed of discovery around this snippet of DNA. Sometimes the machine of science is amazing. 🤩
nickywhiffin.bsky.social
Isn't genetics cool???

Within only 145 nucleotides(!) of a non-coding RNA (RNU4-2) - different variants in distinct regions / structures cause three distinct disorders!!! (all discovered within the last 18 months)

🤯🤓🧬❤️
Schematic of the U4 and U6 snRNAs with coloured annotations to note nucleotides linked to different disorders:
- Teal in the T-loop and Stem III for ReNU syndrome (Chen et al. Nature 2024 and Greene et al. Nature Medicine 2024)
- Red for variants causing a recessive NDD in Stem II, the k-turn and Sm protein binding sites (De Jonghe et al. medRxiv 2025 and Rius & Blakes medRxiv 2025)
- Yellow for the central loop and Retinitis pigmentosa (Quinodoz et al. medRxiv 2025)
alexblakes.bsky.social
Thanks also to the institutions whose incredible resources and platforms have made this work possible, including @ukbiobank.bsky.social, @genomicsengland.bsky.social, @manchester.ac.uk, @ox.ac.uk, as well as our funders including @wellcometrust.bsky.social.